ES253120A1 - PROCEDURE FOR OBTAINING A NEW MEANS OF RADIOLOGICAL CONTRAST - Google Patents

PROCEDURE FOR OBTAINING A NEW MEANS OF RADIOLOGICAL CONTRAST

Info

Publication number
ES253120A1
ES253120A1 ES0253120A ES253120A ES253120A1 ES 253120 A1 ES253120 A1 ES 253120A1 ES 0253120 A ES0253120 A ES 0253120A ES 253120 A ES253120 A ES 253120A ES 253120 A1 ES253120 A1 ES 253120A1
Authority
ES
Spain
Prior art keywords
radical
amino
acid
group
chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0253120A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Patheon Austria GmbH and Co KG
Original Assignee
Chemie Linz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT835958A external-priority patent/AT209897B/en
Priority claimed from AT261559A external-priority patent/AT210564B/en
Priority claimed from AT305259A external-priority patent/AT211953B/en
Priority claimed from AT433959A external-priority patent/AT211816B/en
Application filed by Chemie Linz AG filed Critical Chemie Linz AG
Publication of ES253120A1 publication Critical patent/ES253120A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0495—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452—Solutions, e.g. for injection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Tetra-, penta-, octa- and deca-iodo-benzoic acid amides of the general formula (I) <FORM:0881510/IV (b)/1> wherein Z is a hydrogen or an iodine atom, an amino group or an acylamino group of not more than 4 carbon atoms. Y is a methylene radical or a polymethylene radical of not more than 6 carbon atoms, a cycloalkylene radical or 5 or 6 carbon atoms, or a phenylene radical, and X is a hydrogen atom, or an alkyl, cycloalkyl, aralkyl or aryl radical, which radical may be substituted with a hydroxyl or lower alkoxy group or, in the case where X is an alkyl radical, it may be substituted with the group <FORM:0881510/IV (b)/2> are prepared by a process in which the principle step is the action of the acid chloride having the formula <FORM:0881510/IV (b)/3> on an alkyl ester of the appropriate amino carboxylic acid or diamino dicarboxylic acid. In Example 2, a solution of 3-iodo-5-amino-benzoic acid in hydrochloric acid is reacted with a solution of NaCl.Cl.I in hydrochloric acid to obtain 3-amino-2,4,5,6-tetraiodobenzoic acid, from which the corresponding acid-chloride is then obtained by treatment with thionyl chloride. In Example 7, methyl-N-beta-hydroxy-ethyl-beta1-aminopropionate is heated with 3-amino-2,4,5,6-tetraiodobenzoyl chloride yielding methyl N - (3 - amino - 2,4,5,6 - tetraiodobenzoyl) - N - beta - hydroxyethyl-beta1-aminopropionate and the example also describes the preparation of the free acid and the sodium salt. Example 3 describes the preparation of pentaiodo-benzoyl chloride by the action of thionyl chloride on pentaiodobenzoic acid. The latter is obtained by treating diazotized 3-amino-2,4,5,6-tetraiodo-benzoic acid with KI. In Example 9, pentaiodo-benzoyl chloride is heated with methyl alpha-amino-n-butyrate to give methyl N-(pentaiodo-benzoyl)-alpha-amino-n-butyrate. In Example 12, methyl hexamethylene diamine-N,N1-bis-beta-propionate is reacted with 3-amino-2,4,5,6-tetraiodobenzoyl chloride to give the dimethyl ester of hexamethylene-diamino-N,N1-bis-(3-amino - 2,4,5,6 - tetraiodobenzoyl) - N,N1 - bis - beta-propionic acid. These polyiodated benzoic acid amides are effective X-ray contrast agents (Group VI).ALSO:The invention comprises X-ray contrast compositions comprising a tetra-, penta-, octa-and deca-iodo-benzoic acid amide of the general formula <FORM:0881510/VI/1> wherein Z is a hydrogen or an iodine atom, an amino group or an acylamino group of not more than 4 carbon atoms Y is methylene radical or a polymethylene radical of not more than 6 carbon atoms, a cycloalkylene radical of 5 or 6 carbon atoms, or a phenylene radical and X is a hydrogen atom, or an alkyl, cyclo-alkyl, aralkyl or aryl radical, which radical may be substituted with an hydroxyl or lower alkoxy group or, in the case where X is an alkyl radical, it may be substituted with the group <FORM:0881510/VI/2> or a non-toxic salt of such a polyiodo-benzoic acid amide, with a non-toxic carrier therefor. Non-toxic salts specified are those of sodium, lithium, diethanolamine, and methyl glucosamine. The free acids as well as the non-toxic salts may be processed to form tablets together with binders such as starch, talc, polyethylene glycol, magnesium stearate, lauryl alcohol sulphonate, or both starch and lactic acid. The polyiodo compound may also be mixed with groundnut oil and lecithine, and filled into gelatine capsules.
ES0253120A 1958-12-03 1959-11-03 PROCEDURE FOR OBTAINING A NEW MEANS OF RADIOLOGICAL CONTRAST Expired ES253120A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AT835958A AT209897B (en) 1958-12-03 1958-12-03 Process for the preparation of new O- or N-2,3,4,6-tetraiodobenzoyl compounds
AT261559A AT210564B (en) 1959-04-07 1959-04-07 X-ray contrast medium
AT305259A AT211953B (en) 1959-04-23 1959-04-23 X-ray contrast media
AT433959A AT211816B (en) 1959-06-12 1959-06-12 Process for the preparation of new polyiodinated benzoyl compounds

Publications (1)

Publication Number Publication Date
ES253120A1 true ES253120A1 (en) 1960-05-16

Family

ID=27421801

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0253120A Expired ES253120A1 (en) 1958-12-03 1959-11-03 PROCEDURE FOR OBTAINING A NEW MEANS OF RADIOLOGICAL CONTRAST

Country Status (5)

Country Link
CH (1) CH385423A (en)
ES (1) ES253120A1 (en)
FR (1) FR275M (en)
GB (1) GB881510A (en)
NL (1) NL124839C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2717799B1 (en) * 1994-03-22 1996-07-19 Guerbet Sa Polyiodes compounds: preparation process; diagnostic composition.
GB0717189D0 (en) 2007-09-04 2007-10-17 Syngenta Participations Ag Novel processes and compounds

Also Published As

Publication number Publication date
NL124839C (en) 1968-07-16
GB881510A (en) 1961-11-01
FR275M (en) 1961-03-13
CH385423A (en) 1964-12-15

Similar Documents

Publication Publication Date Title
DE3060434D1 (en) Diamides of triiodo-isophthalic acids, their preparation and x-ray contrast agents containing them
ATE14579T1 (en) PHARMACEUTICAL HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM.
ES8202777A1 (en) Phenol derivatives, processes for their preparation and pharmaceutical compositions containing them.
ES8200645A1 (en) Muramyldipeptide derivatives, process for preparing said compounds and pharmaceutical compositions containing said compounds.
ES391629A1 (en) Pharmaceutical use of certain substituted biguanides
ES304136A1 (en) Procedure for the preparation of new N-substituted amides. (Machine-translation by Google Translate, not legally binding)
IT7850648A0 (en) CRYSTALLINE FORM OF THE SODIUM SALT OF AN OXYMIN DERIVATIVE OF 7-AMINO THIAZOLYL ACETAMIDO EC PHALOSPORANIC ACID PROCEDURE FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN IT
DK119684D0 (en) QUINOLONCARBOXYLIC ACIDS AND THEIR USE AS BACTERICIDES
ES469108A1 (en) N-(1-(3-benzoyl-propyl)-4-piperidyl)-sulfonic acid amides and salts thereof
GB1090466A (en) Phosphorus-containing derivatives of 1-ª‰-d-arabino-furanosylcytosine
GB881510A (en) Iodine-containing benzoic acid amides and a method of producing same
DE69426908D1 (en) Derivatives of phosphonic acid, process for their preparation and pharmaceutical compositions containing them
ES469473A1 (en) N-phenyl-n-(4-piperidinyl)-amides
GB867880A (en) N-acyl derivatives of (3:5-diamino-2:4:6-triiodobenzoyl)-amino acids and x-ray contrast media containing the same
FR2369216A1 (en) WATER TREATMENT PRODUCTS CONTAINING ACYLIMINO DIACETIC ACIDS
GB1332833A (en) Amindines
ES394894A1 (en) Phenylacetohydroxamic acids process for their manufacture and preparations containing them
GB918365A (en) Fungicidal and acaricidal compositions
WO1991017141A3 (en) Diastereoselective process for preparing n-substituted amino acids and derivatives
ES8106147A1 (en) 1,2,4-Triazole-3-thiols as antisecretory agents
SE303829B (en) Injectable X-ray contrast agent composition
ES423681A1 (en) Procedure for preparing pentadians. (Machine-translation by Google Translate, not legally binding)
GB912920A (en) New substituted aminomethanephosphonic acids and processes for their production
US3135791A (en) (dialkylamino)imino bisacetamides
SU568334A3 (en) Herbicide